Samuel Frank

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. ncbi Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
    Samuel Frank
    BMC Neurol 9:62. 2009

Detail Information

Publications1

  1. ncbi Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
    Samuel Frank
    BMC Neurol 9:62. 2009
    ..The objective of this study was to assess the long-term safety and effectiveness of TBZ for chorea in HD...